Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Cyclophosphamide 64fludarabine phosphate 37Peripheral Blood Stem Cell Transplantation 30Cyclosporine 30Radiotherapy 28Mycophenolic Acid 28Filgrastim 28Busulfan 28Whole-Body Irradiation 26Antilymphocyte Serum 24Melphalan 19Etoposide 19Tacrolimus 16Methotrexate 16Cord Blood Stem Cell Transplantation 16Methylprednisolone 15Rituximab 14Thiotepa 10Cytarabine 10Vincristine 8Prednisone 8Doxorubicin 8Carboplatin 7fludarabine 5Sirolimus 5sargramostim 4glofitamab 4aldesleukin 4Therapeutics 4Leucovorin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dendritic Cell Sarcoma, Interdigitating × Lisaftoclax × Clear all
NCT07255963 2025-12-01

Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting
29 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡